(Q24245437)

1 July 2019

meta-analysis

0 references

review article

1 reference

title

Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria (English)

1 reference

1 July 2019

main subject

malaria

0 references

Plasmodium falciparum

0 references

1 reference

3

0 references

author name string

A A A Omari

series ordinal

1

1 reference

1 July 2019

C Gamble

series ordinal

2

1 reference

1 July 2019

publication date

19 October 2005

1 reference

1 July 2019

Cochrane Database of Systematic Reviews

published in

1 reference

1 July 2019

issue

4

1 reference

1 July 2019

page(s)

CD005564

1 reference

1 July 2019

Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Efficacy of therapeutic combinations with artemisinin derivatives in the treatment of non complicated malaria in Burundi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Distinction of recrudescences from new infections by PCR-RFLP analysis in a comparative trial of CGP 56 697 and chloroquine in Tanzanian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Interaction trial between artemether-lumefantrine (Riamet) and quinine in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

The comparative efficacy and tolerability of CGP 56697 (artemether + lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travellers returning from the Tropics to The Netherlands and France

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Cardiac effects of co-artemether (artemether/lumefantrine) and mefloquine given alone or in combination to healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Artemether-lumefantrine (four-dose regimen) for treating uncomplicated falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Antimalarial drug resistance and combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Averting a malaria disaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Artemether-lumefantrine for treating uncomplicated falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

Artemether-lumefantrine for uncomplicated malaria: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005564

A randomized, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand.

21 January 2018

1 reference

12 December 2020

Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria

1 reference

12 December 2020

No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine

1 reference

12 December 2020

A randomized, double-blind, parallel-group, comparative safety, and efficacy trial of oral co-artemether versus oral chloroquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in adults in India.

1 reference

12 December 2020

Combination therapy for malaria in Africa: hype or hope?

1 reference

12 December 2020

A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand

1 reference

12 December 2020

Artemether-lumefantrine for treating uncomplicated falciparum malaria

1 reference

12 December 2020

Efficacy of mefloquine, halofantrine, and coarteme in the treatment of tropical malaria

1 reference

12 December 2020

Clinical comparative trial of co-artemether and benflumetol (two formulations) in the treatment of falciparum malaria

1 reference

12 December 2020

Comparative clinical trial of two-fixed combinations dihydroartemisinin-napthoquine-trimethoprim (DNP) and artemether-lumefantrine (Coartem/Riamet) in the treatment of acute uncomplicated falciparum malaria in Thailand.

1 reference

12 December 2020

Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug, CGP 56697.

2 references

12 December 2020

https://api.crossref.org/works/10.1002%2F14651858.CD005564

7 January 2021

inferred from DOI database lookup

Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria.

1 reference

12 December 2020

A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children

1 reference

12 December 2020

10.1002/14651858.CD005564

Identifiers

DOI

1 reference

1 July 2019

PMCID

6532733

1 reference

1 July 2019

PubMed ID

16235412

1 reference

1 July 2019